Evolving trends in epidemiology, etiology, and treatment patterns for hepatocellular carcinoma in South Korea.
作者信息
Hwang Soo Young, Yang Ju Dong
机构信息
Department of Internal Medicine, University of Maryland Medical Center, Midtown Campus, Baltimore, Maryland, USA.
Karsh Division of Gastroenterology and Hepatology, Comprehensive Transplant Center, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
出版信息
J Liver Cancer. 2025 Mar;25(1):4-6. doi: 10.17998/jlc.2024.12.04. Epub 2024 Dec 5.
Abstract
摘要
相似文献
1
Evolving trends in epidemiology, etiology, and treatment patterns for hepatocellular carcinoma in South Korea.韩国肝细胞癌在流行病学、病因学及治疗模式方面的演变趋势
J Liver Cancer. 2025 Mar;25(1):4-6. doi: 10.17998/jlc.2024.12.04. Epub 2024 Dec 5.
2
Correspondence to editorial on "Evolving trends in epidemiology, etiology, and treatment patterns for hepatocellular carcinoma in South Korea".致关于“韩国肝细胞癌流行病学、病因学及治疗模式的演变趋势”的社论的信函。
J Liver Cancer. 2025 Mar;25(1):7-8. doi: 10.17998/jlc.2025.02.17. Epub 2025 Feb 27.
3
Evolving trends in treatment patterns for hepatocellular carcinoma in Korea from 2008 to 2022: a nationwide population-based study.2008年至2022年韩国肝细胞癌治疗模式的演变趋势：一项基于全国人口的研究。
J Liver Cancer. 2024 Sep;24(2):274-285. doi: 10.17998/jlc.2024.08.13. Epub 2024 Aug 26.
4
Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study.肝细胞癌从诊断到死亡的全球管理模式：BRIDGE研究
Liver Int. 2015 Sep;35(9):2155-66. doi: 10.1111/liv.12818. Epub 2015 Mar 25.
5
Evolving Global Etiology of Hepatocellular Carcinoma (HCC): Insights and Trends for 2024.肝细胞癌（HCC）不断演变的全球病因：2024年的见解与趋势
J Clin Exp Hepatol. 2025 Jan-Feb;15(1):102406. doi: 10.1016/j.jceh.2024.102406. Epub 2024 Aug 28.
6
Current trends in the treatment of hepatocellular carcinoma with transarterial embolization: a cross-sectional survey of techniques.经动脉栓塞治疗肝细胞癌的现状：技术的横断面调查。
Eur Radiol. 2019 Jun;29(6):3287-3295. doi: 10.1007/s00330-018-5782-7. Epub 2018 Oct 22.
7
Evolving epidemiology of non-alcoholic fatty liver disease in South Korea: incidence, prevalence, progression, and healthcare implications from 2010 to 2022.韩国非酒精性脂肪性肝病的流行趋势演变：2010 年至 2022 年的发病率、患病率、进展及对医疗保健的影响。
Korean J Intern Med. 2024 Nov;39(6):931-944. doi: 10.3904/kjim.2024.164. Epub 2024 Oct 24.
8
Decreasing trends in thyroid cancer incidence in South Korea: What happened in South Korea?韩国甲状腺癌发病率呈下降趋势：韩国发生了什么？
Cancer Med. 2021 Jun;10(12):4087-4096. doi: 10.1002/cam4.3926. Epub 2021 May 12.
9
Advancing Korean nationwide registry for hepatocellular carcinoma: a systematic sampling approach utilizing the Korea Central Cancer Registry database.推进韩国全国肝细胞癌登记系统：一种利用韩国中央癌症登记数据库的系统抽样方法。
J Liver Cancer. 2024 Mar;24(1):57-61. doi: 10.17998/jlc.2024.03.03. Epub 2024 Mar 26.
10
Status of hepatocellular carcinoma in South Korea.韩国肝细胞癌的现状。
Chin Clin Oncol. 2013 Dec;2(4):39. doi: 10.3978/j.issn.2304-3865.2013.11.08.
引用本文的文献
1
Correspondence to editorial on "Evolving trends in epidemiology, etiology, and treatment patterns for hepatocellular carcinoma in South Korea".致关于“韩国肝细胞癌流行病学、病因学及治疗模式的演变趋势”的社论的信函。
J Liver Cancer. 2025 Mar;25(1):7-8. doi: 10.17998/jlc.2025.02.17. Epub 2025 Feb 27.
本文引用的文献
1
Local ablation for hepatocellular carcinoma: 2024 expert consensus-based practical recommendation of the Korean Liver Cancer Association.肝细胞癌的局部消融治疗：韩国肝癌协会基于2024年专家共识的实用建议
J Liver Cancer. 2024 Sep;24(2):131-144. doi: 10.17998/jlc.2024.08.04. Epub 2024 Aug 30.
2
Evolving trends in treatment patterns for hepatocellular carcinoma in Korea from 2008 to 2022: a nationwide population-based study.2008年至2022年韩国肝细胞癌治疗模式的演变趋势：一项基于全国人口的研究。
J Liver Cancer. 2024 Sep;24(2):274-285. doi: 10.17998/jlc.2024.08.13. Epub 2024 Aug 26.
3
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma.特瑞利木单抗联合度伐利尤单抗治疗不可切除肝细胞癌。
NEJM Evid. 2022 Aug;1(8):EVIDoa2100070. doi: 10.1056/EVIDoa2100070. Epub 2022 Jun 6.
4
Long-Term Overall Survival After Selective Internal Radiation Therapy for Locally Advanced Hepatocellular Carcinomas: Updated Analysis of DOSISPHERE-01 Trial.选择性内部放射疗法治疗局部晚期肝细胞癌的长期总体生存率：DOSISPHERE-01 试验的更新分析。
J Nucl Med. 2024 Feb 1;65(2):264-269. doi: 10.2967/jnumed.123.266211.
5
Minimally Invasive Anatomic Liver Resection for Hepatocellular Carcinoma Using the Extrahepatic Glissonian Approach: Surgical Techniques and Comparison of Outcomes with the Open Approach and between the Laparoscopic and Robotic Approaches.采用肝外Glissonian入路的肝细胞癌微创解剖性肝切除术：手术技术及与开放手术、腹腔镜手术和机器人手术的疗效比较
Cancers (Basel). 2023 Apr 9;15(8):2219. doi: 10.3390/cancers15082219.
6
Safety and Efficacy of Robotic vs Open Liver Resection for Hepatocellular Carcinoma.机器人与开放式肝切除术治疗肝细胞癌的安全性和疗效。
JAMA Surg. 2023 Jan 1;158(1):46-54. doi: 10.1001/jamasurg.2022.5697.
7
Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors.全球酒精性肝硬化和 HCC 的流行病学：趋势、预测和危险因素。
Nat Rev Gastroenterol Hepatol. 2023 Jan;20(1):37-49. doi: 10.1038/s41575-022-00688-6. Epub 2022 Oct 18.
8
Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer.2010 年至 2019 年全球肝癌流行病学变化：NASH 是肝癌增长最快的病因。
Cell Metab. 2022 Jul 5;34(7):969-977.e2. doi: 10.1016/j.cmet.2022.05.003. Epub 2022 Jun 3.
9
Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.全球、区域和国家乙型肝炎负担，1990-2019 年：基于 2019 年全球疾病负担研究的系统分析。
Lancet Gastroenterol Hepatol. 2022 Sep;7(9):796-829. doi: 10.1016/S2468-1253(22)00124-8. Epub 2022 Jun 21.
10
Epidemiological and Clinical History of Viral Hepatitis in Korea.韩国病毒性肝炎的流行病学与临床病史
Infect Chemother. 2021 Mar;53(1):159-165. doi: 10.3947/ic.2021.0300. Epub 2021 Jan 26.
Zotero 插件